Skin and bones - Mind the gap

Rheumatology

Volumn 43, Issue 6, 2004, Pages 690-691

  Robertson, L ^a   de Berker, David ^a  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; STEROID; TOPICAL AGENT;

ARTHROPATHY; AWARENESS; CONNECTIVE TISSUE DISEASE; DRUG MEGADOSE; EDITORIAL; HEALTH SERVICE; HUMAN; INTERPERSONAL COMMUNICATION; LIVER TOXICITY; LUNG TOXICITY; MEDICAL EDUCATION; MEDICAL SPECIALIST; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RESPONSIBILITY; RHEUMATOID ARTHRITIS; SKIN MANIFESTATION; TEAMWORK; UNITED KINGDOM;

ARTHRITIS, RHEUMATOID; DERMATOLOGY; GREAT BRITAIN; HUMANS; INTERPROFESSIONAL RELATIONS; PATIENT CARE TEAM; RHEUMATOLOGY;

EID: 3042549108     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keh207     Document Type: Editorial

References (10)

1. Griffiths CEM. Therapy for psoriatic arthritis: sometimes a conflict for psoriasis. Br J Rheumatol 1997;36:409-10.
2. Kremer JM, Alacron GS, Lightfoot RW et al. Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. Arthritis Rheum 1994;37:316-28.
3. Zachariae H, Heickendorff L, Søgaard H. The value of amino-terminal propeptide of type III procollagen in routine screening for methotrexate-induced liver fibrosis; a 10-year follow up. Br J Dermatol 2001;43:100-3.
4. Clinical guidelines. Psoriasis. British Association of Dermatologists, 2001. www.bad.org.uk
5. Ebherhardt K, Thorbjorn Jensen L, Horslev-Petersen K, Petterson H, Lorenzen I, Wollheim F. Serum aminoterminal type III procollagen peptide in early rheumatoid arthritis: relation to disease activity and progression of joint damage. Clin Exp Rheumatol 1990; 8:335-40.
6. Hakala M, Aman S, Luukkainen R et al. Application of markers of collagen metabolism in serum and synovial fluid for assessment of disease process in patients with rheumatoid arthritis. Ann Rheum Dis 1995;54:886-90.
7. Tebib JG, Viguier P, Noel E, Colson F, Barbier Y, Bouvier M. Serum N-terminal procollagen iii fragment: a predictive marker of joint destruction in rheumatoid arthritis. Clin Rheumatol 1992; 11:502-7.
8. Kremer JM, Furst DE, Weinblatt ME, Blotner SD. Significant changes in serum AST across hepatic histological biopsy grades: prospective analysis of 3 cohorts receiving methotrexate therapy for rheumatoid arthritis. J Rheumatol 1996;23:459-61.
9. Kremer JM, Kaye GI. Electron microscopic analysis of sequential liver biopsy samples from patients with rheumatoid arthritis. Arthritis Rheum 1989;32:1202-13.
10. Kremer JM, Kaye GI, Kaye NW, Ishak KG, Axiotis CA: Light and electron microscopic analysis of sequential liver biopsy samples from rheumatoid arthritis patients receiving long-term methotrexate therapy. Follow up over long treatment intervals and correlation with clinical and laboratory variables. Arthritis Rheum 1995; 38:1194-203.